Deep Brain Stimulation Lead Localization After Implantation
Research on Lead Localization for Deep Brain Stimulation After Implantation
1 other identifier
interventional
10
1 country
1
Brief Summary
Deep brain stimulation (DBS) is an effective treatment for a variety of neurological and psychiatric disorders, with more than 200,000 patients implanted with DBS devices worldwide. Parkinson's disease is one of the typical indications.The clinical outcomes of DBS depends on the accurate implantation of the lead, and the identification of the lead locations is the basis for evaluating the effectiveness of the treatment. The aim of this study is to localize the implantation position of the lead based on postoperative MRI images and to reconstruct the relative spatial relationship between the lead and the stimulation target. By comparing with the lead position identified based on postoperative CT, this study will evaluate the accuracy of identifying the DBS lead position directly from MRI. This study may help to optimise the stimulation parameters and investigate the best stimulation targets for DBS patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable parkinson-disease
Started Dec 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 10, 2023
CompletedFirst Submitted
Initial submission to the registry
December 25, 2023
CompletedFirst Posted
Study publicly available on registry
January 9, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedJanuary 9, 2024
December 1, 2023
12 months
December 25, 2023
December 25, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Lead position
The accuracy of the lead localization will be evaluated by the distance between the identified position of the lead electrode and the center of the reconstructed stimulation target. The result of lead localization by CT will be used as the reference.
1 day
Study Arms (1)
DBS lead localization
EXPERIMENTALParticipates will receive a head MRI anc CT scan. The stimulation target and the related neural nuclei will be reconstructed using MRI images. The spatial position of the implanted lead will be identified with MRI and CT. Through comparing with the identified lead position by CT, the accuracy of lead localization by MRI will be evaluated.
Interventions
An MRI scan of the head in about 30 minutes. During the scan, MRI thermometry will be performed to monitor for possible lead heating due to the interaction of the MRI radiofrequency field and the implanted devices. An CT plain scan of the head in about 10 minutes.
Eligibility Criteria
You may qualify if:
- Parkinson's disease patients with DBS devices, DBS implanted for at least 1 month.
- Ability to tolerate DBS turn-off for at least 30 minutes.
- DBS devices do not contain the ferromagnetic material.
- The patients can fully understand the content of the trial and sign the informed consent form.
- Able to comply to the requirements of this study.
You may not qualify if:
- Presence of other concomitant diseases that have or require implantation of pacemakers, defibrillators, cochlear implants, or other neurostimulation devices.
- Patients who are abnormally sensitive to temperature or allergic to heat.
- Patients with severe psychiatric disorders or cognitive impairment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Engineering Research Center of Neuromodulation
Beijing, Beijing Municipality, 100084, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
December 25, 2023
First Posted
January 9, 2024
Study Start
December 10, 2023
Primary Completion
December 1, 2024
Study Completion
December 1, 2025
Last Updated
January 9, 2024
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share